Amantadine and the Risk of Dyskinesia in Patients with Early Parkinson’s Disease: An Open-Label, Pragmatic Trial

OBJECTIVE: We examined whether amantadine can prevent the development of dyskinesia. METHODS: Patients with drug-naïve Parkinson’s disease (PD), younger than 70 years of age and in the early stage of PD (Hoehn and Yahr scale < 3), were recruited from April 2011 to December 2014. The exclusion cri...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Aryun, Kim, Young Eun, Yun, Ji Young, Kim, Han-Joon, Yang, Hui-Jun, Lee, Woong-Woo, Shin, Chae Won, Park, Hyeyoung, Jung, Yu Jin, Kim, Ahro, Kim, Yoon, Jang, Mihee, Jeon, Beomseok
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Movement Disorder Society 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5990909/
https://www.ncbi.nlm.nih.gov/pubmed/29860788
http://dx.doi.org/10.14802/jmd.18005

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5990909/
https://www.ncbi.nlm.nih.gov/pubmed/29860788
http://dx.doi.org/10.14802/jmd.18005

Ejemplares similares